Study guide

8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health

Professional and Linguistic Assessments Board Part 1 PLAB 1

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the PLAB 1 Exam

2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies

1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies

3 Chapter 2: Cardiovascular Medicine & Vascular Disorders

2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease

4 Chapter 3: Respiratory Medicine

3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure

5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery

4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD

6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance

5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies

7 Chapter 6: Endocrinology & Metabolic Medicine

6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease

8 Chapter 7: Neurology & Neurosciences

7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders

9 Chapter 8: Psychiatry & Mental Health

8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health

10 Chapter 9: Obstetrics, Gynaecology & Sexual Health

9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence

11 Chapter 10: Paediatrics & Child Health

10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems

12 Chapter 11: Musculoskeletal Medicine & Rheumatology

11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders

13 Chapter 12: Dermatology, ENT & Ophthalmology

12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer

14 Chapter 13: Haematology, Oncology & Palliative Care

13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral

15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology

14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship

16 Chapter 15: Medical Ethics, Law & UK Clinical Practice

15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse

17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention

16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention

18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging

17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays

8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health

Key Takeaways Explain This Topic AI

Postpartum psychosis usually starts within 2 weeks of birth, is strongly linked to bipolar disorder, and needs urgent admission, ideally to a mother and baby unit.

Baby blues affect up to 80% of mothers on days 3–10 and resolve within 2 weeks, whereas postnatal depression lasts longer and may need CBT or an antidepressant.

Fluoxetine is the first-line antidepressant for moderate to severe depression in children and young people, started by a specialist alongside psychological therapy (NICE NG134).

Methylphenidate is the first-line medicine for ADHD in children aged 5 and over after diagnosis by a specialist, with monitoring of height, weight, heart rate and blood pressure.

People with a learning disability are offered an annual health check from age 14, and reasonable adjustments are a legal duty.

Last updated: October 2026

  • Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
  • Perinatal Mental Health (NICE CG192)

At booking and in the postnatal period, ask the Whooley questions (low mood and loss of interest over the past month) and the GAD-2; use the Edinburgh Postnatal Depression Scale or PHQ-9 if positive. Ask about past or present severe mental illness and family history of bipolar disorder or postpartum psychosis .

Condition Onset & Frequency Features Management

Baby blues Days 3–10; up to 80% of mothers Tearfulness, emotional lability, anxiety Reassurance; resolves within 2 weeks

Postnatal depression Within the first year; about 10–15% Low mood, anhedonia, guilt about mothering, intrusive thoughts, poor sleep beyond the baby's needs Guided self-help, CBT; antidepressant if moderate or severe ( sertraline is commonly used in breastfeeding)

Postpartum (puerperal) psychosis Usually within 2 weeks ; 1–2 per 1,000 births Rapid onset of mania, psychosis, confusion, rapidly changing mood Psychiatric emergency : urgent assessment (within 4 hours) and admission, ideally to a mother and baby unit

Warning

Highest-Risk Women: Women with bipolar disorder or a previous postpartum psychosis have a very high risk of postpartum relapse. They need a written perinatal mental health plan, specialist perinatal team input in pregnancy, and close monitoring in the first weeks after birth. Suicide is a leading cause of maternal death in the year after pregnancy in the UK.

Psychotropic Drugs in Pregnancy

Valproate must not be used in women and girls able to have children unless they are in the Pregnancy Prevention Programme, and should be avoided in pregnancy (neural tube and other malformations, neurodevelopmental harm).

Lithium in the first trimester is linked to cardiac malformations (Ebstein's anomaly); if continued, levels need close monitoring, especially at delivery.

Decisions balance the risk of relapse against fetal risk and should involve a perinatal psychiatrist.

Depression & Self-Harm in Children and Young People (NICE NG134)

Less severe depression: watchful waiting, then digital CBT , group CBT, group non-directive supportive therapy or group IPT.

More severe depression: refer to child and adolescent mental health services (CAMHS) for individual CBT, interpersonal therapy for adolescents or family therapy.

Antidepressants: fluoxetine is the first-line drug , used only after assessment by a specialist and in combination with psychological therapy ; monitor closely for agitation and suicidal thoughts, especially early in treatment.

Self-harm: every young person who self-harms needs a psychosocial assessment (NICE NG225), consideration of safeguarding (abuse, exploitation, neglect), involvement of parents or carers where appropriate, and a safety plan. Admission to a paediatric ward after significant self-harm by under-16s is common practice.

Attention Deficit Hyperactivity Disorder (ADHD, NICE NG87)

A neurodevelopmental condition with inattention , hyperactivity and impulsivity present in more than one setting (home and school), starting in childhood (DSM-5: several symptoms before age 12) and causing impairment.

Diagnosis is made by a specialist (paediatrician, child psychiatrist or adult ADHD service) using history from several sources; there is no diagnostic blood test or scan.

Under 5: ADHD-focused parent training first.

Children aged 5 and over and young people: ADHD-focused support and environmental adjustments (school), then methylphenidate as first-line medication ; lisdexamfetamine if a 6-week trial of methylphenidate has not helped; atomoxetine or guanfacine as alternatives.

Adults: lisdexamfetamine or methylphenidate first-line.

Before and during stimulants: record height, weight, heart rate and blood pressure (stimulants suppress appetite and growth and raise heart rate and BP), ask about cardiac symptoms and family history of sudden death, and monitor regularly. Stimulants are controlled drugs and affect driving rules.

Autism

Persistent differences in social communication and interaction with restricted, repetitive behaviours and interests and sensory differences, present from early childhood. Red flags include lack of joint attention or pointing by about 12–18 months, absent babbling or social smiling, and loss of language or social skills. Diagnosis follows multidisciplinary assessment (NICE recommends starting within 3 months of referral). There are no medicines for the core features; support focuses on communication, education and environmental adjustments, while coexisting conditions (ADHD, anxiety, epilepsy, sleep problems, learning disability) are treated. Distressed behaviour should prompt a search for pain, illness or sensory triggers.

Learning Disability

A significant impairment of intellectual functioning (IQ below about 70) and adaptive functioning that starts in childhood. Causes include Down's syndrome, fragile X syndrome, fetal alcohol spectrum disorder and perinatal brain injury.

Annual health checks are offered from age 14 in England.

Clinicians must make reasonable adjustments (Equality Act 2010), such as longer appointments and easy-read information, and assess capacity for each decision under the Mental Capacity Act.

Beware diagnostic overshadowing (attributing new symptoms to the learning disability) and inappropriate psychotropic prescribing (the STOMP programme aims to stop overmedication).

The LeDeR programme reviews the deaths of people with a learning disability and autistic people to reduce avoidable deaths.

Other Childhood Presentations

Conduct disorder: persistent antisocial or aggressive behaviour; group parent training programmes are first-line.

Tic disorders and Tourette's syndrome: motor and vocal tics for more than a year; behavioural therapy for troublesome tics.

Anxiety in children (separation anxiety, selective mutism, school refusal): CBT-based approaches with parent involvement.

Gender Incongruence

Some people experience gender incongruence (a mismatch between experienced gender and sex registered at birth), which may cause distress ( gender dysphoria ). Doctors should be respectful (using the person's chosen name and pronouns), assess and support mental health, and refer to NHS gender services for specialist assessment. For children and young people, NHS England children and young people's gender services provide holistic multidisciplinary care, and since 2024 puberty-suppressing hormones are not routinely prescribed to under-18s for gender incongruence outside research . Confidentiality, capacity and safeguarding principles apply as for any other healthcare decision.

Loading diagram...